Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways.
Carbone F, Vuilleumier N, Bertolotto M, Burger F, Galan K, Roversi G, Tamborino C, Casetta I, Seraceni S, Trentini A, Dallegri F, da Silva AR, Pende A, Artom N, Mach F, Coen M, Fainardi E, Montecucco F.
Carbone F, et al. Among authors: trentini a.
Vascul Pharmacol. 2015 Jan;64:16-27. doi: 10.1016/j.vph.2014.11.007. Epub 2014 Dec 18.
Vascul Pharmacol. 2015.
PMID: 25530154
Free article.